178 related articles for article (PubMed ID: 11323859)
1. Avoiding the challenges of emerging infectious disease and antibiotic resistance.
Molinari JA
J Mass Dent Soc; 2000; 49(3):8-9, 51. PubMed ID: 11323859
[No Abstract] [Full Text] [Related]
2. Back from the dead. Emerging and re-emerging infectious diseases.
Cornell S
Adv Nurse Pract; 1998 May; 6(5):67-8. PubMed ID: 9633297
[No Abstract] [Full Text] [Related]
3. Microbial disease trends and acquired antibiotic resistance: Part 1.
Molinari JA
Compend Contin Educ Dent; 1997 Feb; 18(2):106-8. PubMed ID: 9452530
[No Abstract] [Full Text] [Related]
4. Infectious diseases in Wisconsin: a public health perspective.
Davis JP
WMJ; 2000 Aug; 99(5):12-21. PubMed ID: 11043063
[No Abstract] [Full Text] [Related]
5. Infective disorders.
Lahiri A
J Indian Med Assoc; 2000 Jul; 98(7):367. PubMed ID: 11143854
[No Abstract] [Full Text] [Related]
6. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.
Temime L; Hejblum G; Setbon M; Valleron AJ
Epidemiol Infect; 2008 Mar; 136(3):289-98. PubMed ID: 17767792
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of infectious diseases 1966].
Riva G
Praxis; 1967 Mar; 56(13):434-9. PubMed ID: 5631838
[No Abstract] [Full Text] [Related]
8. [Antibiotics and ecology in the Third World].
Midtvedt T
Tidsskr Nor Laegeforen; 1991 May; 111(13):1636-7. PubMed ID: 2063364
[TBL] [Abstract][Full Text] [Related]
9. [The etiotropic therapy of infectious diseases].
Pokrovskiĭ VI; Maleev VV
Ter Arkh; 1993; 65(11):4-7. PubMed ID: 8108796
[No Abstract] [Full Text] [Related]
10. Introduction: antibiotic short-course therapy---where are the limits?
Finch RG
J Int Med Res; 2000; 28 Suppl 1():1A-2A. PubMed ID: 11092224
[No Abstract] [Full Text] [Related]
11. Key pathogens and emerging therapies in infectious diseases.
Miller PF; Mueller JP
Curr Opin Pharmacol; 2009 Oct; 9(5):535-6. PubMed ID: 19766536
[No Abstract] [Full Text] [Related]
12. Emerging infectious diseases and America's readiness.
Jennings PR
JAAPA; 2002 Apr; 15(4):6, 9. PubMed ID: 12012588
[No Abstract] [Full Text] [Related]
13. [The infrequency and exceptionality of infectious pathology].
Soriano F
Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):465-7. PubMed ID: 8305551
[No Abstract] [Full Text] [Related]
14. Millennium bugs.
Pennington H
Biologist (London); 2000 Apr; 47(2):93-5. PubMed ID: 11190237
[TBL] [Abstract][Full Text] [Related]
15. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
Paterson DL; Rice LB
Clin Infect Dis; 2003 Apr; 36(8):1006-12. PubMed ID: 12684913
[TBL] [Abstract][Full Text] [Related]
16. Executive summary: global antimicrobial resistance alerts and implications.
Alliance for the Prudent Use of Antibiotics
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S221-3. PubMed ID: 16032555
[No Abstract] [Full Text] [Related]
17. Tackling antibiotic resistance in India.
Wattal C; Goel N
Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1427-40. PubMed ID: 25353717
[TBL] [Abstract][Full Text] [Related]
18. Conclusion: ESCMID declaration on meeting the challenges in clinical microbiology and infectious diseases.
Struelens MJ; Van Eldere J
Clin Microbiol Infect; 2005 Apr; 11 Suppl 1():50-1. PubMed ID: 15760445
[No Abstract] [Full Text] [Related]
19. Global antibiotic resistance and its impact on the dental community.
Pallasch TJ
J Calif Dent Assoc; 2000 Mar; 28(3):215-33. PubMed ID: 11326536
[TBL] [Abstract][Full Text] [Related]
20. Critical care clinics.
Cunha BA
Crit Care Clin; 2008 Apr; 24(2):xiii-xvi. PubMed ID: 18361942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
